PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company has had multiple discussions with the German Federal Association of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Rumors Trading Halts

Wedbush Downgrades PTC Therapeutics (PTCT) to NeutralMarch 1, 2016 7:29 AM Cowen Downgrades PTC Therapeutics (PTCT) to Market PerformMarch 1, 2016 7:27 AM Germany Seeks PTC Therapeutics (PTCT) Translarna Discount - OppenheimerFebruary 29, 2016 9:32 AM PTC Therapeutics Provides Update on German pricing and Reimbursement Process for Translarna™ (ataluren)February 26, 2016 4:01 PM PTC Therapeutics (PTCT) Shares Decline; German Reimbursement Arbitration Panel Said to Cut Price of Ataluren by 65%February 26, 2016 3:37 PM